Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys in Treatment-Experienced Chronic Hepatitis B
NCT00226382Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2005
- Primary completion
- Apr 2008
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of interferon alfa in Chronic Hepatitis B (CHB), sponsored by The Chinese University of Hong Kong. Started Jan 2005; status: completed.
02
Drugs
interferon alfa
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00226382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226382.